Massachusetts Financial Services Co. MA Boosts Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Massachusetts Financial Services Co. MA raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,435,086 shares of the medical device company's stock after acquiring an additional 44,826 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 0.72% of Cooper Companies worth $121,050,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Price T Rowe Associates Inc. MD increased its holdings in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after acquiring an additional 2,957,421 shares in the last quarter. Norges Bank purchased a new position in shares of Cooper Companies in the 4th quarter worth about $217,906,000. FMR LLC raised its position in shares of Cooper Companies by 97.6% in the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after purchasing an additional 1,095,805 shares during the last quarter. SG Americas Securities LLC raised its position in shares of Cooper Companies by 8,337.0% in the 1st quarter. SG Americas Securities LLC now owns 369,542 shares of the medical device company's stock worth $31,171,000 after purchasing an additional 365,162 shares during the last quarter. Finally, Northern Trust Corp raised its position in shares of Cooper Companies by 15.4% in the 4th quarter. Northern Trust Corp now owns 2,018,898 shares of the medical device company's stock worth $185,597,000 after purchasing an additional 268,972 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

COO traded down $0.63 during mid-day trading on Friday, reaching $72.63. 1,870,502 shares of the company traded hands, compared to its average volume of 1,764,686. The stock has a market capitalization of $14.52 billion, a P/E ratio of 35.26, a P/E/G ratio of 1.77 and a beta of 0.99. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The company's fifty day moving average price is $74.23 and its 200-day moving average price is $82.18. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.85 EPS. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Mizuho lowered their price target on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. JPMorgan Chase & Co. restated a "neutral" rating and issued a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Finally, Loop Capital set a $100.00 price objective on shares of Cooper Companies in a report on Tuesday, June 17th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $97.20.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.